Tonix Pharmaceuticals Holding Corp. logo
Tonix Pharmaceuticals Holding Corp. TNXP
$ 0.14 -2.07%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Tonix Pharmaceuticals Holding Corp. Financial Ratios 2011-2024 | TNXP

Annual Financial Ratios Tonix Pharmaceuticals Holding Corp.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.0 -0.0 -0.9 -2.5 -0.1 -0.1 -1.3 -0.4 -1.7 -2.3 -4.4 - -

P/S

0.4 - - - - - - - - - - - -

EPS

-6.8 -20.0 -8.1 -0.6 -19.3 -259.9 -31.7 -15.4 -28.6 -2.8 -3.4 -5.6 -3.2

EV (Enterprise Value)

27.2 M -97.7 M -69 M 58.1 M -3.98 M -20.2 M 3.44 M -2.42 M 68.8 M 27.6 M 41.6 M -627 K 2.84 M

EBITDA per Share

-6.7 -19 -8.1 -0.397 -17.9 -240 -318 -1.54 K -2.86 K -2.77 K -3.36 K - -

EV/EBITDA

-25.6 -0.9 0.3 0.9 -0.1 0.1 -1.3 -0.9 -3.6 0.2 -

PEG

-0.0 -0.0 -0.0 0.04 -0.0 -0.01 -0.02 -0.01 0.52 -0.13 -0.11 - -

P/B

0.0 0.0 0.4 1.4 0.2 0.1 1.1 0.6 2.0 1.7 7.3 - -

P/CF

-0.0 -0.0 -1.2 -2.2 -0.1 -0.1 -1.4 -0.4 -1.9 -2.7 -5.6 - -

ROE %

-110.55 -53.20 -42.19 -57.57 -303.90 -110.25 -85.81 -153.16 -119.35 -76.52 -167.14 -984.38 -

ROA %

-75.53 -48.84 -38.31 -51.40 -196.58 -99.13 -78.95 -141.19 -102.20 -69.84 -124.59 -445.75 -

ROCE %

-112.18 -54.10 -42.21 -57.16 -305.93 -111.23 -86.45 -153.46 -119.31 -76.48 -166.87 -964.29 -

Current Ratio

3.2 12.2 10.9 9.0 2.7 9.8 12.4 12.8 7.0 11.5 3.9 1.8 -

DSO

- - - - - - - - - - - - -

DIO

525.0 - - - - - - - - - - - -

DPO

456.2 - - - - - - - - - - - -

Operating Cycle

525.0 - - - - - - - - - - - -

Cash Conversion Cycle

68.9 - - - - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Tonix Pharmaceuticals Holding Corp.

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.23 -19.28 -0.18 - -38.63 -49.23 -3.21 - -4.24 -7.64 -1.61 - -1.6 -2.25 -0.07 - -0.09 -0.23 -0.37 - -5.69 -9.42 -12.76 - -54.99 -7.23 -8.8 - -0.77 -0.65 -1.27 - -2.9 -4.97 -7.41 -0.71 -0.72 -0.73 -0.71 -0.83 -0.71 -0.61 -0.59 - -0.87 -0.95 -0.93 - -0.05 -1.01 -1.27 - -0.05 -0.02 -0.03

EBITDA per Share

-0.24 -18.7 -0.25 - -37.5 -48.8 -3.21 - -4.29 -6.48 -1.6 - -1.6 -2.25 -0.07 - -0.09 -0.23 -0.3 - -5.71 -9.5 -12.9 - -55.2 -7.26 -8.85 - -0.77 -0.65 -1.27 - -2.9 -4.97 -7.4 -7.12 -0.72 -0.73 -0.71 -0.83 -0.71 -0.61 -0.59 - -0.87 -0.95 -0.92 - -0.05 -1.01 -0.73 - -0.05 -0.02 -0.02

ROE %

-243.22 -247.22 -80.31 -63.29 -75.95 -65.46 -55.41 -35.50 -44.66 -41.16 -44.08 -33.89 -47.57 -52.08 -55.21 -38.15 -121.39 -190.94 -236.78 -211.44 -234.59 -174.51 -138.22 -78.18 -101.69 -102.04 -95.73 -63.50 -93.38 -99.75 -119.00 -123.65 -156.84 -159.87 -150.42 -119.35 -111.08 -98.72 -86.25 -76.52 -99.06 -125.96 -141.24 -110.21 -290.87 -424.09 -572.72 -571.50 -530.16 -308.16 -113.00 76.77 41.34 14.50 20.93

ROA %

-158.13 -163.25 -68.96 -56.27 -68.21 -60.07 -50.70 -32.13 -40.76 -37.44 -41.51 -32.33 -44.54 -48.13 -50.12 -34.06 -87.90 -129.53 -155.20 -136.77 -157.59 -124.57 -107.58 -70.30 -91.92 -92.73 -87.47 -58.42 -85.97 -91.89 -109.67 -113.99 -142.41 -143.04 -132.42 -102.20 -96.52 -87.10 -77.37 -69.84 -82.48 -99.09 -107.68 -82.15 -163.96 -210.40 -268.33 -258.79 -497.24 -653.88 -655.71 -442.82 -238.45 -83.63 -120.73

ROCE %

-247.63 -249.97 -86.98 -64.44 -77.36 -66.99 -56.57 -35.86 -45.03 -41.27 -44.10 -33.94 -47.63 -52.16 -55.29 -38.21 -122.00 -192.11 -238.63 -213.38 -236.80 -176.42 -139.66 -78.90 -102.61 -102.90 -96.53 -63.97 -93.98 -100.28 -119.47 -124.04 -157.33 -160.31 -150.80 -119.62 -111.28 -98.90 -86.39 -76.63 -99.16 -126.04 -141.32 -110.24 -291.15 -424.57 -573.44 -482.84 -441.50 -219.26 -23.85 76.78 41.34 14.50 20.93

Current Ratio

4.6 2.5 5.0 3.2 7.5 8.3 13.1 12.2 17.7 16.9 14.2 10.9 17.1 21.8 27.8 9.3 9.3 9.3 9.3 2.8 2.8 2.8 2.8 9.9 9.9 9.9 9.9 12.5 12.5 12.5 12.5 12.8 12.8 12.8 12.8 7.0 7.0 7.0 7.0 11.5 11.5 11.5 11.5 3.9 3.9 3.9 3.9 1.8 1.8 1.8 1.8 0.1 0.1 0.1 0.1

DSO

118.9 - - - 17.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

510.2 295.5 714.3 - 519.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

420.8 231.1 286.7 - 297.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

629.0 295.5 714.3 - 537.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

208.3 64.4 427.6 - 239.8 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency